The German Center for Neurodegenerative Diseases (German: Deutsches Zentrum für Neurodegenerative Erkrankungen, (DZNE)) is an interdisciplinary research institution that investigates neurodegenerative disease in all its facets.
The Latest Bing News on:
German Center for Neurodegenerative Diseases Research
- What an Alzheimer’s Controversy Reveals About the Pressures of Academia
In 2006, a study of Alzheimer’s disease by the lead author Sylvain Lesné met those criteria: It suggested a new culprit for the illness, a molecule called Aβ*56, which seemingly caused dementia ...
- Genentech to Present Scientific Progress Across Alzheimer’s Disease Pharmaceutical and Diagnostic Portfolio at 2022 AAIC Annual Meeting
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data from 41 abstracts across its portfolio of Alzheimer’s disease pharmaceuticals and diagnostics will be ...
- Anti-amyloid drugs and Alzheimer’s disease
An estimated 50 million people around the world have Alzheimer’s disease (AD), and perhaps twice that number are unknowingly “incubating” the disease during its long presymptomatic period. The total ...
- Anti-amyloid drugs and Alzheimer's disease
An estimated 50 million people around the world have Alzheimer's disease (AD), and perhaps twice that number are unknowingly "incubating" the disease during its long presymptomatic period.
- Alzheimer's disease and anti-amyloid therapeutic approaches
In this up-to-the-minute assessment, publishing July 21 st in the open access journal PLOS Biology, Christian Haass at the German Center for Neurodegenerative ... Alzheimer's disease worldwide.
The Latest Google Headlines on:
German Center for Neurodegenerative Diseases Research
The Latest Bing News on:
German Center for Neurodegenerative Diseases Discovery
- Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis
will position AIxplorerBio at the forefront in the AI drug discovery race to bring better treatment options to patients with autoimmune diseases. CDE Accepted the IND Application of Genhouse's ...
- New Huntington’s Disease System Will “Revolutionize” Drug Trials
The new system assesses the progression of Huntington’s disease. As part of an international consortium, researchers from the University College London (UCL) have developed a novel staging framework ...
- AC Immune Announces Upcoming Presentations at the Alzheimer’s Association International Conference
clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced 10 upcoming presentations that will be delivered at the Alzheimer’s ...
- Could Huntington’s disease begin before birth?
Neurodegenerative disorders can have a neurodevelopmental component, as researcher find Huntington's disease could begin in utero.
- Research initiative studies prevention of neurodegenerative diseases
Working with UC Berkeley researchers, the Glaucoma Research Foundation launched a research initiative July 15 studying neurodegenerative diseases.
